(Q40265657)

English

A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity

scientific article published on 3 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity (English)

1 reference

Europe PubMed Central

19 September 2017

0 references

yellow fever virus

0 references

1 reference

based on heuristic

inferred from title

object named as

Carlos del Rio

7

0 references

object named as

Rama S Akondy

4

0 references

Alan D T Barrett

11

object named as

Alan Barrett

1 reference

Europe PubMed Central

19 September 2017

Robert S. Lanciotti

5

object named as

Robert Lanciotti

1 reference

Europe PubMed Central

19 September 2017

Srilatha Edupuganti

1

object named as

Srilatha Edupuganti

1 reference

Europe PubMed Central

19 September 2017

Walter A. Orenstein

6

object named as

Walter Orenstein

1 reference

Europe PubMed Central

19 September 2017

Harry L Keyserling

3

object named as

Harry Keyserling

1 reference

Europe PubMed Central

19 September 2017

12

object named as

Rafi Ahmed

1 reference

Europe PubMed Central

19 September 2017

Mark J Mulligan

15

object named as

Mark J Mulligan

1 reference

Europe PubMed Central

19 September 2017

Martin S Cetron

14

object named as

Martin Cetron

1 reference

Europe PubMed Central

19 September 2017

author name string

Rachel B Eidex

2

1 reference

Europe PubMed Central

19 September 2017

Yi Pan

8

1 reference

Europe PubMed Central

19 September 2017

Troy Querec

9

1 reference

Europe PubMed Central

19 September 2017

Harvey Lipman

10

1 reference

Europe PubMed Central

19 September 2017

Dirk Teuwen

13

1 reference

Europe PubMed Central

19 September 2017

YF-Ig Study Team

16

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

3 December 2012

1 reference

Europe PubMed Central

19 September 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

American Journal of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

19 September 2017

88

1 reference

Europe PubMed Central

19 September 2017

1

1 reference

Europe PubMed Central

19 September 2017

172-177

1 reference

Europe PubMed Central

19 September 2017

The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Evaluation of Chimeric Japanese Encephalitis and Dengue Viruses for Use in Diagnostic Plaque Reduction Neutralization Tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Human immune memory to yellow fever and smallpox vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Adverse event reports following yellow fever vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Acute viscerotropic disease following vaccination against yellow fever

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996-2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Yellow fever vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Comparison of the immunogenicity and safety of two 17D yellow fever vaccines.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

The effect of immune globulin on the response to trivalent oral poliovirus and yellow fever vaccinations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

Serum dilution neutralization test for California group virus identification and serology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

22 September 2017

CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

25 September 2017

Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

25 September 2017

VACCINATION AGAINST YELLOW FEVER WITH IMMUNE SERUM AND VIRUS FIXED FOR MICE.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

25 September 2017

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

17 June 2018

History of thymoma and yellow fever vaccination

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541731

20 August 2018

Identifiers

10.4269/AJTMH.2012.12-0179

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40265657&oldid=2116990946"